SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,990,000 | -27.1% | 1,837,500 | 0.0% | 0.08% | -14.4% |
| Q3 2021 | $8,214,000 | -18.0% | 1,837,500 | 0.0% | 0.09% | -10.9% |
| Q2 2021 | $10,014,000 | -27.1% | 1,837,500 | 0.0% | 0.10% | -21.7% |
| Q1 2021 | $13,745,000 | -18.9% | 1,837,500 | +17.6% | 0.13% | -12.8% |
| Q4 2020 | $16,953,000 | – | 1,562,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |